Supported by

Mitral valve replacement and repair

Latest mitral valve replacement and repair content in interventional cardiology - research, practice, and education

Building on the years of experience with TAVI, mitral valve replacement and repair (TMVR) is now beginning to take-off with a vast array of new techniques and options. Certain devices, for instance in mitral repair, are now widely used. To understand this complex field a knowledge and mastery is required covering the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Mitral valve replacement and repair

634 results

Secondary mitral regurgitation: not all patients are the same

20 May 2026 – From EuroPCR 2026

Examining secondary mitral regurgitation, this session differentiates patient phenotypes and discusses the application of updated guideline recommendations. It offers practical guidance on selecting the appropriate device tailored to individual patient characteristics, supported by detailed case studies.

Secondary mitral regurgitation: not all patients are the same

How to obtain a surgical-liked result in a patient with primary mitral regurgitation?

20 May 2026 – From EuroPCR 2026

This session delves into achieving surgical-like outcomes in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair (TEER). It covers anatomical criteria for optimal patient selection, essential procedural steps including device choice and imaging guidance, and key factors contributing to durable success and patient improvement.

How to obtain a surgical-liked result in a patient with primary mitral regurgitation?

Transcatheter mitral interventions: outcomes and new procedural approaches

20 May 2026 – From EuroPCR 2026

This session covers transcatheter mitral interventions, comparing surgical and transcatheter approaches, including TEER and TMVR. It presents clinical outcomes, safety data, and innovative procedural techniques such as transeptal BATMAN to prevent left ventricular outflow tract obstruction during TMVR.

Transcatheter mitral interventions: outcomes and new procedural approaches

Registries and trials in mitral TEER

20 May 2026 – From EuroPCR 2026

This comprehensive session reviews registries and clinical trials in mitral transcatheter edge-to-edge repair (TEER). It includes discussions on novel TEER systems, international consensus on PASCAL implants, anatomical predictors of procedural success, and long-term outcomes including ventricular and atrial remodeling after intervention, as well as emerging therapies...

Beyond the horizon - Future of structural heart innovations and PCI

20 May 2026 – From EuroPCR 2026

Structural heart and coronary interventions are expanding rapidly, with innovation increasingly focused on managing complex anatomies and diversifying treatment strategies.

The PRISM-PCI toolkit is introduced as a framework to support decision-making in complex PCI, alongside advances in transcatheter valve therapies spanning mitral, tricuspid and pulmonary interventions, as...

Beyond the horizon - Future of structural heart innovations and PCI

Advancing mitral transcatheter edge-to-edge repair in complex lesions

20 May 2026 – From EuroPCR 2026

Learn how advanced imaging, careful anatomical assessment and tailored procedural strategies are helping expand the possibilities of mitral transcatheter edge-to-edge repair (M-TEER) in complex lesions.

Focusing on atrial secondary mitral regurgitation (SMR) and commissural mitral regurgitation, this EuroPCR 2026 session reviews evidence, showing that M-TEER can be...

Advancing mitral transcatheter edge-to-edge repair in complex lesions

Innovation in action: achieving optimal outcomes in mitral regurgitation

20 May 2026 – From EuroPCR 2026

A growing mitral valve portfolio is reshaping how mitral regurgitation is treated, offering tailored solutions across a broader range of patient anatomies and clinical scenarios.

This EuroPCR 2026 session focuses on innovations in transcatheter mitral therapies, highlighting how mitral transcatheter edge-to-edge repair (TEER) with the PASCAL Precision...

Innovation in action: achieving optimal outcomes in mitral regurgitation

Advancing mitral care with the Intrepid TMVR system

20 May 2026 – From EuroPCR 2026

This EuroPCR 2026 session explores the Intrepid transcatheter mitral valve replacement (TMVR) system and its role in expanding treatment options for patients with mitral regurgitation, including complex anatomies such as mitral annular calcification (MAC).

It highlights how the system’s design features and procedural imaging support a streamlined...

Advancing mitral care with the Intrepid TMVR system

How should I treat a patient with a calcified mitral anatomy?

19 May 2026 – From EuroPCR 2026

This session explores the management of patients with calcified mitral anatomy, from advanced imaging assessment to intervention planning. It evaluates the suitability of mitral annular calcification for transcatheter edge-to-edge repair (TEER) and discusses alternative therapeutic options for patients ineligible for TEER.

How should I treat a patient with a calcified mitral anatomy?

When the anterior leaflet gets in the way: mitral leaflet modification before TMVR

19 May 2026 – From EuroPCR 2026

This session addresses the intricacies of mitral leaflet modification techniques prior to transcatheter mitral valve replacement (TMVR). It features innovative approaches such as LAMPOON-assisted valve-in-ring replacement, balloon-assisted leaflet translocation, and strategies to overcome the challenges posed by mitral annular calcification.